ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Medical Workers Face Hidden Cancer Risk from Sterilization Gas; New Test from Air by CCSquared Offers Early Detection

Sterilization gas lingers in packaging materials and outgasses during shipping, delivery, storage, and use—posing invisible risks to medical

workers.

 

 

A growing body of government data now shows that workers exposed to ethylene oxide (ETO)-a common gas used to sterilize medical equipment-may face severe cancer risks under outdated federal safety limits. As a result, Air by CCSquared Inc. has launched a new, ultra-sensitive ETO airtest to help workers and employers understand their exposure and take Action. 

 

According to the U.S. Environmental Protection Agency (EPA), the exposure to 0.01 ppb for a lifetime causes no more than 1 cancer in approximately 10,000 people, or 100,000 times lower than the current OSHA limit of 1000 ppb, a value accepted for decades as a safe concentration in the workplace. EPA modeling shows that chronic exposure to ETO at OSHA’s legal limit could increase lifetime cancer risk to greater than 1 in 10—a level which public health experts call unacceptable. 

 

With the ability to detect ETO concentrations as low as 2 parts per billion (ppb), the test provides an unprecedented layer of protection for workers, especially those in high-risk environments such as sterilization facilities, medical clinics, warehouses, and homes near industrial operations.

Key features of the Air by CCSquared ETO test include:

● High Sensitivity to 2 ppb – Offers early detection at levels far below conventional badge style monitors, enabling faster protective actions.

ISO 17025:2017 Accreditation – Ensures all results are scientifically defensible, reproducible, and trusted for regulatory and legal contexts.

Field-Ready Sampling Kits – Simple, flexible kits are designed for use in workplaces, clinics, warehouses, or residential settings.

● Expert Interpretation Support – Helps individuals and organizations understand their results and plan appropriate next steps.

 

“This test isn’t just about compliance—it’s about access, transparency, and protection,” said Dr. William Chapman, founder and CEO of Air by

CCSquared. “People have the right to know what’s in their air they breathe and how it could affect their health. With this tool, we’re giving them real data they can finally act on.”

 

How Community Risk Research Uncovered this Workplace Crisis

The EPA initially modeled ETO risk to assess ambient air levels in communities near sterilization and chemical manufacturing facilities. But those models revealed something even larger: the real danger may lie inside these facilities and throughout the medical supply chain all the way to the

customer, where exposure is frequent, direct, and currently unmonitored at high sensitivity.

 

The EPA finding has sparked dozens of lawsuits from medical professionals, warehouse workers, sterilization technicians, and others in the medical device supply chain who suffer from cancer after long-term ETO exposure on the job. “EPA’s community health studies inadvertently exposed a workplace safety gap that had gone unaddressed for decades,” said Dr. Chapman. “Our new test is designed to help close that gap and protect workers' lives.

 

About Air by CCSquared Inc.

Air by CCSquared Inc. is a science-driven air testing company committed to safeguarding worker and community health. Founded by chemist William Chapman, PhD, the company brings decades of experience in industrial hygiene, environmental science, and analytical chemistry. Air by CCSquared specializes in next-generation technologies for testing for hazardous airborne compounds in both occupational and residential settings, particularly where traditional monitoring methods fall short. 

 

Through ISO 17025:2017-accredited laboratory methods and precision

instruments capable of detecting pollutants at parts-per-billion levels, the company helps clients meet regulatory standards, maintain safer indoor environments, and make informed decisions based on reliable data.

 

About William Chapman, PhD

William Chapman, PhD, is a chemist and the founder of Air by CCSquared Inc., an air testing company specializing in analytical tools for evaluating occupational and environmental exposure to airborne chemicals. His background combines expertise in analytical chemistry, airborne

contaminant measurement, and the medical sciences that inform toxicological risk.

 

Dr. Chapman leads the development of precision air sampling and laboratory methods, such as parts-per-billion detection of ethylene oxide, to support industrial hygiene, workplace safety, and environmental health applications. His work centers on applying validated science to real-world problems, helping clients in healthcare, manufacturing, and logistics understand and control the air their people breathe.

 

“Almost every medical device needs to be sterile, but every worker deserves to be safe. We developed our new ethylene oxide test with higher sensitivity to support the millions of medical professionals and community members whose health has been overlooked in the conversation about sterilization gas exposure,” said William Chapman, founder of Air by CCSquared.

air@chapmancc.com

Media Contact

Name
Air by CCSquared Inc
Contact name
William Chapman
Contact phone
(510) 205-1865
Country
United States
Url
https://airbyccsquared.com/

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.